Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 6925357, 8 pages
http://dx.doi.org/10.1155/2016/6925357
Clinical Study

Transcatheter Arterial Infusion of Autologous CD133+ Cells for Diabetic Peripheral Artery Disease

1Department of Interventional and Vascular Surgery, Shanghai Tenth People’s Hospital, Tongji University, No. 301 Middle Yan Chang Road, Shanghai 200072, China
2Institution of Interventional and Vascular Surgery, Tongji University, No. 301 Middle Yan Chang Road, Shanghai 200072, China
3Department of Interventional Radiology, Nanjing First Hospital, No. 68 Changle Road, Nanjing, Jiangsu 210001, China
4Unité de Recherche INSERM 602, 94807 Villejuif Cedex, France

Received 13 October 2015; Revised 10 December 2015; Accepted 4 January 2016

Academic Editor: Yingmei Feng

Copyright © 2016 Xiaoping Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Invernici, C. Emanueli, P. Madeddu et al., “Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia,” The American Journal of Pathology, vol. 170, no. 6, pp. 1879–1892, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. R. Baraniak and T. C. McDevitt, “Stem cell paracrine actions and tissue regeneration,” Regenerative Medicine, vol. 5, no. 1, pp. 121–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Maggini, G. Mirkin, I. Bognanni et al., “Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile,” PLoS ONE, vol. 5, no. 2, Article ID e9252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Kalish and A. Hamdan, “Management of diabetic foot problems,” Journal of Vascular Surgery, vol. 51, no. 2, pp. 476–486, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. Rosenberg and J. C. Watson, “Treatment of painful diabetic peripheral neuropathy,” Prosthetics and Orthotics International, vol. 39, pp. 17–28, 2015. View at Google Scholar
  6. L. Graziani, A. Silvestro, V. Bertone et al., “Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity,” European Journal of Vascular and Endovascular Surgery, vol. 33, no. 4, pp. 453–460, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. E. Sumpio, T. Lee, and P. A. Blume, “Vascular evaluation and arterial reconstruction of the diabetic foot,” Clinics in Podiatric Medicine and Surgery, vol. 20, no. 4, pp. 689–708, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. K. Kota, S. K. Kota, L. K. Meher, S. Sahoo, S. Mohapatra, and K. D. Modi, “Surgical revascularization techniques for diabetic foot,” Journal of Cardiovascular Disease Research, vol. 4, no. 2, pp. 79–83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Esato, K. Hamano, T.-S. Li et al., “Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease,” Cell Transplantation, vol. 11, no. 8, pp. 747–752, 2002. View at Google Scholar · View at Scopus
  10. D. W. Losordo, M. R. Kibbe, F. Mendelsohn et al., “A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia,” Circulation: Cardiovascular Interventions, vol. 5, no. 6, pp. 821–830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. P. Murphy, J. H. Lawson, B. M. Rapp et al., “Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia,” Journal of Vascular Surgery, vol. 53, no. 6, pp. 1565.e1–1574.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. N. Raval, E. G. Schmuck, G. Tefera et al., “Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial,” Cytotherapy, vol. 16, no. 12, pp. 1720–1732, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Tateishi-Yuyama, H. Matsubara, T. Murohara et al., “Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial,” The Lancet, vol. 360, no. 9331, pp. 427–435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. E. B. Friedrich, K. Walenta, J. Scharlau, G. Nickenig, and N. Werner, “CD34/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities,” Circulation Research, vol. 98, no. 3, pp. e20–e25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. U. M. Gehling, S. Ergün, U. Schumacher et al., “In vitro differentiation of endothelial cells from AC133-positive progenitor cells,” Blood, vol. 95, no. 10, pp. 3106–3112, 2000. View at Google Scholar · View at Scopus
  16. N. Ma, Y. Ladilov, J. M. Moebius et al., “Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: bone marrow vs. Cord blood-derived cells,” Cardiovascular Research, vol. 71, no. 1, pp. 158–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Raval and D. W. Losordo, “Cell therapy of peripheral arterial disease: from experimental findings to clinical trials,” Circulation Research, vol. 112, no. 9, pp. 1288–1302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Peichev, A. J. Naiyer, D. Pereira et al., “Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors,” Blood, vol. 95, no. 3, pp. 952–958, 2000. View at Google Scholar · View at Scopus
  19. C. Y. L. Chao and G. L. Y. Cheing, “Microvascular dysfunction in diabetic foot disease and ulceration,” Diabetes/Metabolism Research and Reviews, vol. 25, no. 7, pp. 604–614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Zhou, K. H. Wu, M.-C. Poon, and Z. C. Han, “Endothelial progenitor cells transfected with PDGF: cellular and molecular targets for prevention of diabetic microangiopathy,” Medical Hypotheses, vol. 67, no. 6, pp. 1308–1312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. G. P. Fadini, C. Agostini, and A. Avogaro, “Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature,” Atherosclerosis, vol. 209, pp. 10–17, 2009. View at Google Scholar
  23. M. Gnecchi, Z. Zhang, A. Ni, and V. J. Dzau, “Paracrine mechanisms in adult stem cell signaling and therapy,” Circulation Research, vol. 103, no. 11, pp. 1204–1219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. E. Di Cesare, E. Chang, C. F. Preston, and C.-J. Liu, “Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty,” The Journal of Bone & Joint Surgery—American Volume, vol. 87, no. 9, pp. 1921–1927, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-P. Bastard, C. Jardel, E. Bruckert et al., “Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 9, pp. 3338–3342, 2000. View at Google Scholar · View at Scopus
  26. A. Tuttolomondo, S. La Placa, D. Di Raimondo et al., “Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity,” Cardiovascular Diabetology, vol. 9, article 50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Asahara, T. Takahashi, H. Masuda et al., “VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells,” The EMBO Journal, vol. 18, no. 14, pp. 3964–3972, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. S. E. Epstein, S. Fuchs, Y. F. Zhou, R. Baffour, and R. Kornowski, “Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards,” Cardiovascular Research, vol. 49, no. 3, pp. 532–542, 2001. View at Publisher · View at Google Scholar · View at Scopus